A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa

Stroke Clinical Trial

— FEVRIER  

Official title:

A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03231449
• Other study ID #: 001
• Status: Active, not recruiting
• Start date: February 1, 2017
• Est. completion date: February 2021

Study information

• Verified date: May 2018
• Source: Cardiologie et Développement
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

FEVRIER study is an observatory of hospitalizations in cardiology units in sub-Saharan Africa.

Description:

FEVRIER is an observational study based on a questionnaire completed by investigators for each hospitalization in cardiology unit during the month of February.The investigator is a physician of the participating hospital.

FEVRIER evaluates the modalities of care management. It will take place in cardiology units of hospitals of sub-Saharian countries one month per year (month of February) during 5 years.

The investigator will thoroughly complete:

• one information form describing the hospital and the department

• one questionnaire (2o questions) for each hospitalized patient

Patients with at least one day of hospitalization will be enrolled in the study. On the first day of February, all patients already hospitalized will be enrolled and all patients hospitalized in the last day of February will be followed until their discharge. thus, data collection will start 1st day of investigation, during February and will continue until the discharge of the last enrolled patient.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 5000
• Est. completion date: February 2021
• Est. primary completion date: December 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• to be hospitalized in a cardiology department of a participating center during the month of February

Exclusion Criteria:

• refusal

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Arrhythmias, Cardiac
• Conduction Abnormalities
• Deep Vein Thrombosis
• Embolism
• Endocarditis
• Heart Failure
• Other Cardiovascular Conditions
• Pericarditis
• Pulmonary Embolism
• Rhythm; Abnormal
• Stroke
• Syncope
• Thrombosis
• Venous Thrombosis

Intervention

Other:
• observation of current care
The study FEVRIER (survey of hospitalizations in cardiology units in sub-Saharan Africa) aims to establish a description of sub-Saharan standard of care, in order to get a cross sectional analysis (globally and per country) and a longitudinal analysis (evolution during 5 years).

Locations

Country	Name	City	State
Benin	Centre national hospitalier et universitaire Koutoukou Maga	Cotonou
Burkina Faso	Centre médical Paul IV	Ouagadougou
Burundi	Hopital militaire de Kamenge et polyclinique maison médicale	Bujumbura
Cameroon	Hôpital Régional	Bafoussam
Cameroon	Douala General Hospital	Douala
Cameroon	Central Hospital	Yaounde
Cameroon	Hôpital Général de Yaoundé	Yaounde
Congo	CHU	Brazzaville
Congo, The Democratic Republic of the	Clinique Ngaliema	Kinshasa
Congo, The Democratic Republic of the	Clinique universitaire de Kinshasa	Kinshasa
Côte D'Ivoire	Institut de Cariologie d'Abidjan	Abidjan
Côte D'Ivoire	CHU	Bouake
Gabon	Centre Hospitalier Universitaire (CHUL)	Libreville
Guinea	CHU Ignace Deen	Conakry
Mozambique	Institut du coeur	Maputo
Niger	Hôpital National Lamorde	Niamey
Senegal	Hôpital de Fann	Dakar
Senegal	Hôpital général de Grand Yoff	Dakar
Senegal	El Hadj-Ibrahima Niass	Kaolac
Sudan	National Cardiothoracic center / Shab Teaching Hospital	Khartoum

Sponsors (2)

Lead Sponsor	Collaborator
Cardiologie et Développement	Institut National de la Santé Et de la Recherche Médicale, France

Countries where clinical trial is conducted

Benin,  Burkina Faso,  Burundi,  Cameroon,  Congo,  Congo, The Democratic Republic of the,  Côte D'Ivoire,  Gabon,  Guinea,  Mozambique,  Niger,  Senegal,  Sudan, 

References & Publications (6)

Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, Mocumbi AO, Paquet C, Sidi D, Jouven X. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009 Aug 25;120(8):663-8. doi: 10.1161/CIRCULATIONAHA.109.849190. Epub 2009 Aug 10. — View Citation

Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012 Mar 10;379(9819):953-64. doi: 10.1016/S0140-6736(11)61171-9. Review. — View Citation

Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007 Aug 2;357(5):470-6. — View Citation

Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Sidi D, Jouven X. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ. 2008 Feb;86(2):84. — View Citation

Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, Diagne I, Sanogo I, Kingue S, Chelo D, Wamba G, Diarra M, Anzouan JB, N'Guetta R, Diakite CO, Traore Y, Legueun G, Deme-Ly I, Belinga S, Boidy K, Kamara I, Tharaux PL, Jouven X. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Haematol. 2014 Nov;1(2):e64-73. doi: 10.1016/S2352-3026(14)00007-6. Epub 2014 Oct 28. — View Citation

Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Description of patients in cardiology unit in sub-Saharan Africa:socio-demographic characterization	low/medium low / medium high/high	5 years
Primary	Description of patients in cardiology unit in sub-Saharan Africa:causes of hospitalization	one answer with main reason for hospitalization	5 years
Primary	Description of patients in cardiology unit in sub-Saharan Africa: co-morbidities	cardiovascular risk factors/history of cardiovascular disease/kidney disease/cancer/alcoholism/psychiatric disorder/sickle cell anemia/HIV:Hepatitis/tuberculosis/other	5 years
Primary	Description of patients in cardiology unit in sub-Saharan Africa: hospital examinations	blood test/ECG/Chest Xray/Echocardiography/Coronarography/Brain scan	5 years
Primary	Description of patients in cardiology unit in sub-Saharan Africa: duration of hospitalization	number of days spent in cardiology departement	5 years
Primary	Description of patients in cardiology unit in sub-Saharan Africa: discharge diagnosis	medical conclusion	5 years
Secondary	number of patients with heart failure	to measure the evolution of the number of patients with heart failure over 5 years	5 years
Secondary	number of patients with myocardial infarction	to measure the evolution of the number of patients with myocardial infarction over 5 years	5 years
Secondary	number of patients with atrial fibrillation	to measure the evolution of the number of patients with atrial fibrillation over 5 years	5 years